LQ0Dextech Medical ABLQ0 info
$0.41info2.76%24h
Global rank33484
Market cap$7.59M
Change 7d5.68%
YTD Performance11.04%
SP500 benchmarkUnderperform
P/E-1.65
P/S0
Revenue$0
Earnings-$449.67K
Dividend yield-
Main Sector
Healthcare

Dextech Medical AB (LQ0) Stock Overview

Dextech Medical AB engages in the development of drug candidates with application in urological oncology, primarily prostate cancer. Its principal product candidate is OsteoDex that has completed phase IIb clinical trial for the treatment of skeletal metastases in castration resistant prostate cancer, as well as in preclinical stage to treat breast and lung cancer, as well as multiple myeloma. The company is also developing SomaDex, a medication candidate that is based on an endogenous hormone, somatostatin, to treat acromegaly, neuroendocrine tumors, and palliative treatment for advanced prostate cancer; and PSMA-binding conjugates for the target-specific treatment of mCRPC that overexpresses prostate specific membrane antigen (PSMA). In addition, the company offers GuaDex (formarly CatDex), a technology platform and a charge-modified dextran molecule with tumor-toxic properties used for medication development. Dextech Medical AB was incorporated in 2004 and is based in Uppsala, Sweden.

LQ0 Stock Information

Symbol
LQ0
Address
Dag Hammarskjölds Väg 34AUppsala, 752 37Sweden
Founded
-
Trading hours
-
Website
https://www.dextechmedical.com
Country
🇸🇪 Sweden
Phone Number
46 7 07 10 47 88

Dextech Medical AB (LQ0) Price Chart

-
Value:-

Dextech Medical AB Overview: Key Details and Summary

Stock data
2023
Change
Price
$0.41347115705235077
N/A
Market Cap
$7.59M
N/A
Shares Outstanding
18.36M
8.02%
Employees
1.00
N/A
Shareholder Equity
34.31M
-11.74%
Valuation
2023
Change
P/E Ratio
-1.65
N/A
P/B Ratio
0.22
N/A
Growth
2023
Change
Return on Equity
-0.0131
N/A
Earnings
2023
Change
Revenue
$0
N/A
Earnings
-$449.67K
N/A
EPS
-0.25
N/A
Earnings Yield
-0.6046
N/A
Financial Strength
2023
Change
Total Assets
$3.43M
N/A
Cash on Hand
$2.47M
N/A
Debt to Equity
0.0021
14.33%
Current Ratio
$35.95
-28.97%
logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org